How to Accelerate Early Drug Development in Oncology For Small Molecules and Biologics
Summary: Get an insight into what it takes to move a pre-clinical drug candidate to a Phase 1 clinical trial. The presentations will provide guidance on non-clinical and regulatory considerations for early drug development of oncology drugs. In addition, we will also provide expert advice into molecule developability assessment, early formulation strategies and non-clinical activities of both small molecules and biologics from lead candidate selection to Phase 1.